# å•ç»†èƒRNA-seqæ•°æ®åˆ†æå·¥ä½œæµç¨‹æŠ¥å‘Š

## æ¦‚è§ˆ

- **åˆ†æè®ºæ–‡æ•°**: 17
- **è¯†åˆ«æ­¥éª¤æ•°**: 7
- **è¯†åˆ«å·¥å…·æ•°**: 0

## åˆ†ææµç¨‹æ­¥éª¤

### 1. Normalization

- **æè¿°**: åœ¨ 4 ç¯‡è®ºæ–‡ä¸­æåˆ° 4 æ¬¡
- **ç›¸å…³è®ºæ–‡æ•°**: 4

**ç›¸å…³è®ºæ–‡åŠå¼•ç”¨**:

**[1.1] Current best practices in single-cell RNA-seq analysis: a tutorial.**

- ä½œè€…: Luecken MD, Theis FJ
- å¹´ä»½: 2019
- å¼•ç”¨æ•°: 1641
- DOI: [10.15252/msb.20188746](https://doi.org/10.15252/msb.20188746)
- PubMed: [PMID:31217225](https://pubmed.ncbi.nlm.nih.gov/31217225/)
- **æåŠå†…å®¹**: "Here, we detail the steps of a typical single-cell RNA-seq analysis, including pre-processing (quality control, normalization, data correction, feature selection, and dimensionality reduction) and cell- and gene-level downstream analysis."

**[1.2] Single-Cell RNA Sequencing Analysis: A Step-by-Step Overview.**

- ä½œè€…: Slovin S, Carissimo A, Panariello F ç­‰
- å¹´ä»½: 2021
- å¼•ç”¨æ•°: 160
- DOI: [10.1007/978-1-0716-1307-8_19](https://doi.org/10.1007/978-1-0716-1307-8_19)
- PubMed: [PMID:33835452](https://pubmed.ncbi.nlm.nih.gov/33835452/)
- **æåŠå†…å®¹**: "Here we provide an overview of the currently available single-cell technologies for cell isolation and library preparation and a step by step guide that covers the entire canonical analytic workflow to analyse scRNA-seq data including read mapping, quality controls, gene expression quantification, normalization, feature selection, dimensionality reduction, and cell clustering useful for trajectory inference and differential expression."

**[1.3] Single-cell protein analysis by mass-spectrometry**

- ä½œè€…: Nikolai Slavov
- å¹´ä»½: 2020
- å¼•ç”¨æ•°: 122
- DOI: [10.1016/j.cbpa.2020.04.018](https://doi.org/10.1016/j.cbpa.2020.04.018)
- arXiv: [2004.02069](https://arxiv.org/abs/2004.02069)
- **æåŠå†…å®¹**: "Mass-spectrometry is the most powerful method for protein analysis, but its application to single cells faces three major challenges: Efficiently delivering proteins/peptides to MS detectors, identifying their sequences, and scaling the analysis to many thousands of single cells."

**[1.4] Guidelines for bioinformatics of single-cell sequencing data analysis in Alzheimer's disease: review, recommendation, implementation and application.**

- ä½œè€…: Wang M, Song WM, Ming C ç­‰
- å¹´ä»½: 2022
- å¼•ç”¨æ•°: 0
- DOI: [10.1186/s13024-022-00517-z](https://doi.org/10.1186/s13024-022-00517-z)
- PubMed: [PMID:35236372](https://pubmed.ncbi.nlm.nih.gov/35236372/)
- **æåŠå†…å®¹**: "Here we systematically review the state-of-the-art bioinformatics approaches to analyze single-cell sequencing data and their applications to AD in 14 major directions, including 1) quality control and normalization, 2) dimension reduction and feature extraction, 3) cell clustering analysis, 4) cell type inference and annotation, 5) differential expression, 6) trajectory inference, 7) copy number variation analysis, 8) integration of single-cell multi-omics, 9) epigenomic analysis, 10) gene network inference, 11) prioritization of cell subpopulations, 12) integrative analysis of human and mouse sc-RNA-seq data, 13) spatial transcriptomics, and 14) comparison of single cell AD mouse model studies and single cell human AD studies."


### 2. Feature Selection

- **æè¿°**: åœ¨ 2 ç¯‡è®ºæ–‡ä¸­æåˆ° 2 æ¬¡
- **ç›¸å…³è®ºæ–‡æ•°**: 2

**ç›¸å…³è®ºæ–‡åŠå¼•ç”¨**:

**[2.1] Current best practices in single-cell RNA-seq analysis: a tutorial.**

- ä½œè€…: Luecken MD, Theis FJ
- å¹´ä»½: 2019
- å¼•ç”¨æ•°: 1641
- DOI: [10.15252/msb.20188746](https://doi.org/10.15252/msb.20188746)
- PubMed: [PMID:31217225](https://pubmed.ncbi.nlm.nih.gov/31217225/)
- **æåŠå†…å®¹**: "Here, we detail the steps of a typical single-cell RNA-seq analysis, including pre-processing (quality control, normalization, data correction, feature selection, and dimensionality reduction) and cell- and gene-level downstream analysis."

**[2.2] Single-Cell RNA Sequencing Analysis: A Step-by-Step Overview.**

- ä½œè€…: Slovin S, Carissimo A, Panariello F ç­‰
- å¹´ä»½: 2021
- å¼•ç”¨æ•°: 160
- DOI: [10.1007/978-1-0716-1307-8_19](https://doi.org/10.1007/978-1-0716-1307-8_19)
- PubMed: [PMID:33835452](https://pubmed.ncbi.nlm.nih.gov/33835452/)
- **æåŠå†…å®¹**: "Here we provide an overview of the currently available single-cell technologies for cell isolation and library preparation and a step by step guide that covers the entire canonical analytic workflow to analyse scRNA-seq data including read mapping, quality controls, gene expression quantification, normalization, feature selection, dimensionality reduction, and cell clustering useful for trajectory inference and differential expression."


### 3. Dimensionality Reduction

- **æè¿°**: åœ¨ 2 ç¯‡è®ºæ–‡ä¸­æåˆ° 2 æ¬¡
- **ç›¸å…³è®ºæ–‡æ•°**: 2

**ç›¸å…³è®ºæ–‡åŠå¼•ç”¨**:

**[3.1] Current best practices in single-cell RNA-seq analysis: a tutorial.**

- ä½œè€…: Luecken MD, Theis FJ
- å¹´ä»½: 2019
- å¼•ç”¨æ•°: 1641
- DOI: [10.15252/msb.20188746](https://doi.org/10.15252/msb.20188746)
- PubMed: [PMID:31217225](https://pubmed.ncbi.nlm.nih.gov/31217225/)
- **æåŠå†…å®¹**: "Here, we detail the steps of a typical single-cell RNA-seq analysis, including pre-processing (quality control, normalization, data correction, feature selection, and dimensionality reduction) and cell- and gene-level downstream analysis."

**[3.2] Single-Cell RNA Sequencing Analysis: A Step-by-Step Overview.**

- ä½œè€…: Slovin S, Carissimo A, Panariello F ç­‰
- å¹´ä»½: 2021
- å¼•ç”¨æ•°: 160
- DOI: [10.1007/978-1-0716-1307-8_19](https://doi.org/10.1007/978-1-0716-1307-8_19)
- PubMed: [PMID:33835452](https://pubmed.ncbi.nlm.nih.gov/33835452/)
- **æåŠå†…å®¹**: "Here we provide an overview of the currently available single-cell technologies for cell isolation and library preparation and a step by step guide that covers the entire canonical analytic workflow to analyse scRNA-seq data including read mapping, quality controls, gene expression quantification, normalization, feature selection, dimensionality reduction, and cell clustering useful for trajectory inference and differential expression."


### 4. Clustering

- **æè¿°**: åœ¨ 3 ç¯‡è®ºæ–‡ä¸­æåˆ° 3 æ¬¡
- **ç›¸å…³è®ºæ–‡æ•°**: 3

**ç›¸å…³è®ºæ–‡åŠå¼•ç”¨**:

**[4.1] Single-Cell RNA Sequencing Analysis: A Step-by-Step Overview.**

- ä½œè€…: Slovin S, Carissimo A, Panariello F ç­‰
- å¹´ä»½: 2021
- å¼•ç”¨æ•°: 160
- DOI: [10.1007/978-1-0716-1307-8_19](https://doi.org/10.1007/978-1-0716-1307-8_19)
- PubMed: [PMID:33835452](https://pubmed.ncbi.nlm.nih.gov/33835452/)
- **æåŠå†…å®¹**: "Here we provide an overview of the currently available single-cell technologies for cell isolation and library preparation and a step by step guide that covers the entire canonical analytic workflow to analyse scRNA-seq data including read mapping, quality controls, gene expression quantification, normalization, feature selection, dimensionality reduction, and cell clustering useful for trajectory inference and differential expression."

**[4.2] Deep Learning in Single-Cell Analysis**

- ä½œè€…: Dylan Molho, Jiayuan Ding, Zhaoheng Li ç­‰
- å¹´ä»½: 2022
- å¼•ç”¨æ•°: 27
- DOI: [10.1145/3641284](https://doi.org/10.1145/3641284)
- arXiv: [2210.12385](https://arxiv.org/abs/2210.12385)
- **æåŠå†…å®¹**: "We then review seven popular tasks spanning through different stages of the single-cell analysis pipeline, including multimodal integration, imputation, clustering, spatial domain identification, cell-type deconvolution, cell segmentation, and cell-type annotation."

**[4.3] Guidelines for bioinformatics of single-cell sequencing data analysis in Alzheimer's disease: review, recommendation, implementation and application.**

- ä½œè€…: Wang M, Song WM, Ming C ç­‰
- å¹´ä»½: 2022
- å¼•ç”¨æ•°: 0
- DOI: [10.1186/s13024-022-00517-z](https://doi.org/10.1186/s13024-022-00517-z)
- PubMed: [PMID:35236372](https://pubmed.ncbi.nlm.nih.gov/35236372/)
- **æåŠå†…å®¹**: "Here we systematically review the state-of-the-art bioinformatics approaches to analyze single-cell sequencing data and their applications to AD in 14 major directions, including 1) quality control and normalization, 2) dimension reduction and feature extraction, 3) cell clustering analysis, 4) cell type inference and annotation, 5) differential expression, 6) trajectory inference, 7) copy number variation analysis, 8) integration of single-cell multi-omics, 9) epigenomic analysis, 10) gene network inference, 11) prioritization of cell subpopulations, 12) integrative analysis of human and mouse sc-RNA-seq data, 13) spatial transcriptomics, and 14) comparison of single cell AD mouse model studies and single cell human AD studies."


### 5. Differential Expression

- **æè¿°**: åœ¨ 3 ç¯‡è®ºæ–‡ä¸­æåˆ° 3 æ¬¡
- **ç›¸å…³è®ºæ–‡æ•°**: 3

**ç›¸å…³è®ºæ–‡åŠå¼•ç”¨**:

**[5.1] Methods for ChIP-seq analysis: A practical workflow and advanced applications.**

- ä½œè€…: Nakato R, Sakata T
- å¹´ä»½: 2021
- å¼•ç”¨æ•°: 166
- DOI: [10.1016/j.ymeth.2020.03.005](https://doi.org/10.1016/j.ymeth.2020.03.005)
- PubMed: [PMID:32240773](https://pubmed.ncbi.nlm.nih.gov/32240773/)
- **æåŠå†…å®¹**: "Genome-wide analysis of histone modifications, such as enhancer analysis and genome-wide chromatin state annotation, enables systematic analysis of how the epigenomic landscape contributes to cell identity, development, lineage specification, and disease."

**[5.2] Single-Cell RNA Sequencing Analysis: A Step-by-Step Overview.**

- ä½œè€…: Slovin S, Carissimo A, Panariello F ç­‰
- å¹´ä»½: 2021
- å¼•ç”¨æ•°: 160
- DOI: [10.1007/978-1-0716-1307-8_19](https://doi.org/10.1007/978-1-0716-1307-8_19)
- PubMed: [PMID:33835452](https://pubmed.ncbi.nlm.nih.gov/33835452/)
- **æåŠå†…å®¹**: "Here we provide an overview of the currently available single-cell technologies for cell isolation and library preparation and a step by step guide that covers the entire canonical analytic workflow to analyse scRNA-seq data including read mapping, quality controls, gene expression quantification, normalization, feature selection, dimensionality reduction, and cell clustering useful for trajectory inference and differential expression."

**[5.3] Guidelines for bioinformatics of single-cell sequencing data analysis in Alzheimer's disease: review, recommendation, implementation and application.**

- ä½œè€…: Wang M, Song WM, Ming C ç­‰
- å¹´ä»½: 2022
- å¼•ç”¨æ•°: 0
- DOI: [10.1186/s13024-022-00517-z](https://doi.org/10.1186/s13024-022-00517-z)
- PubMed: [PMID:35236372](https://pubmed.ncbi.nlm.nih.gov/35236372/)
- **æåŠå†…å®¹**: "Here we systematically review the state-of-the-art bioinformatics approaches to analyze single-cell sequencing data and their applications to AD in 14 major directions, including 1) quality control and normalization, 2) dimension reduction and feature extraction, 3) cell clustering analysis, 4) cell type inference and annotation, 5) differential expression, 6) trajectory inference, 7) copy number variation analysis, 8) integration of single-cell multi-omics, 9) epigenomic analysis, 10) gene network inference, 11) prioritization of cell subpopulations, 12) integrative analysis of human and mouse sc-RNA-seq data, 13) spatial transcriptomics, and 14) comparison of single cell AD mouse model studies and single cell human AD studies."


### 6. Trajectory Analysis

- **æè¿°**: åœ¨ 3 ç¯‡è®ºæ–‡ä¸­æåˆ° 3 æ¬¡
- **ç›¸å…³è®ºæ–‡æ•°**: 3

**ç›¸å…³è®ºæ–‡åŠå¼•ç”¨**:

**[6.1] Methods for ChIP-seq analysis: A practical workflow and advanced applications.**

- ä½œè€…: Nakato R, Sakata T
- å¹´ä»½: 2021
- å¼•ç”¨æ•°: 166
- DOI: [10.1016/j.ymeth.2020.03.005](https://doi.org/10.1016/j.ymeth.2020.03.005)
- PubMed: [PMID:32240773](https://pubmed.ncbi.nlm.nih.gov/32240773/)
- **æåŠå†…å®¹**: "Genome-wide analysis of histone modifications, such as enhancer analysis and genome-wide chromatin state annotation, enables systematic analysis of how the epigenomic landscape contributes to cell identity, development, lineage specification, and disease."

**[6.2] Single-Cell RNA Sequencing Analysis: A Step-by-Step Overview.**

- ä½œè€…: Slovin S, Carissimo A, Panariello F ç­‰
- å¹´ä»½: 2021
- å¼•ç”¨æ•°: 160
- DOI: [10.1007/978-1-0716-1307-8_19](https://doi.org/10.1007/978-1-0716-1307-8_19)
- PubMed: [PMID:33835452](https://pubmed.ncbi.nlm.nih.gov/33835452/)
- **æåŠå†…å®¹**: "Here we provide an overview of the currently available single-cell technologies for cell isolation and library preparation and a step by step guide that covers the entire canonical analytic workflow to analyse scRNA-seq data including read mapping, quality controls, gene expression quantification, normalization, feature selection, dimensionality reduction, and cell clustering useful for trajectory inference and differential expression."

**[6.3] Guidelines for bioinformatics of single-cell sequencing data analysis in Alzheimer's disease: review, recommendation, implementation and application.**

- ä½œè€…: Wang M, Song WM, Ming C ç­‰
- å¹´ä»½: 2022
- å¼•ç”¨æ•°: 0
- DOI: [10.1186/s13024-022-00517-z](https://doi.org/10.1186/s13024-022-00517-z)
- PubMed: [PMID:35236372](https://pubmed.ncbi.nlm.nih.gov/35236372/)
- **æåŠå†…å®¹**: "Here we systematically review the state-of-the-art bioinformatics approaches to analyze single-cell sequencing data and their applications to AD in 14 major directions, including 1) quality control and normalization, 2) dimension reduction and feature extraction, 3) cell clustering analysis, 4) cell type inference and annotation, 5) differential expression, 6) trajectory inference, 7) copy number variation analysis, 8) integration of single-cell multi-omics, 9) epigenomic analysis, 10) gene network inference, 11) prioritization of cell subpopulations, 12) integrative analysis of human and mouse sc-RNA-seq data, 13) spatial transcriptomics, and 14) comparison of single cell AD mouse model studies and single cell human AD studies."


### 7. Quality Control

- **æè¿°**: åœ¨ 5 ç¯‡è®ºæ–‡ä¸­æåˆ° 5 æ¬¡
- **ç›¸å…³è®ºæ–‡æ•°**: 5

**ç›¸å…³è®ºæ–‡åŠå¼•ç”¨**:

**[7.1] Current best practices in single-cell RNA-seq analysis: a tutorial.**

- ä½œè€…: Luecken MD, Theis FJ
- å¹´ä»½: 2019
- å¼•ç”¨æ•°: 1641
- DOI: [10.15252/msb.20188746](https://doi.org/10.15252/msb.20188746)
- PubMed: [PMID:31217225](https://pubmed.ncbi.nlm.nih.gov/31217225/)
- **æåŠå†…å®¹**: "Here, we detail the steps of a typical single-cell RNA-seq analysis, including pre-processing (quality control, normalization, data correction, feature selection, and dimensionality reduction) and cell- and gene-level downstream analysis."

**[7.2] Single-Cell RNA Sequencing Analysis: A Step-by-Step Overview.**

- ä½œè€…: Slovin S, Carissimo A, Panariello F ç­‰
- å¹´ä»½: 2021
- å¼•ç”¨æ•°: 160
- DOI: [10.1007/978-1-0716-1307-8_19](https://doi.org/10.1007/978-1-0716-1307-8_19)
- PubMed: [PMID:33835452](https://pubmed.ncbi.nlm.nih.gov/33835452/)
- **æåŠå†…å®¹**: "Here we provide an overview of the currently available single-cell technologies for cell isolation and library preparation and a step by step guide that covers the entire canonical analytic workflow to analyse scRNA-seq data including read mapping, quality controls, gene expression quantification, normalization, feature selection, dimensionality reduction, and cell clustering useful for trajectory inference and differential expression."

**[7.3] Data analysis guidelines for single-cell RNA-seq in biomedical studies and clinical applications.**

- ä½œè€…: Su M, Pan T, Chen QZ ç­‰
- å¹´ä»½: 2022
- å¼•ç”¨æ•°: 71
- DOI: [10.1186/s40779-022-00434-8](https://doi.org/10.1186/s40779-022-00434-8)
- PubMed: [PMID:36461064](https://pubmed.ncbi.nlm.nih.gov/36461064/)
- **æåŠå†…å®¹**: "Here, we review the workflow for typical scRNA-seq data analysis, covering raw data processing and quality control, basic data analysis applicable for almost all scRNA-seq data sets, and advanced data analysis that should be tailored to specific scientific questions."

**[7.4] Byzantine-Resilient SGD in High Dimensions on Heterogeneous Data**

- ä½œè€…: Deepesh Data, Suhas Diggavi
- å¹´ä»½: 2020
- å¼•ç”¨æ•°: 43
- DOI: [10.1109/ISIT45174.2021.9518248](https://doi.org/10.1109/ISIT45174.2021.9518248)
- arXiv: [2005.07866](https://arxiv.org/abs/2005.07866)
- **æåŠå†…å®¹**: "At the core of our algorithm, we use the polynomial-time outlier-filtering procedure for robust mean estimation proposed by Steinhardt et al."

**[7.5] Guidelines for bioinformatics of single-cell sequencing data analysis in Alzheimer's disease: review, recommendation, implementation and application.**

- ä½œè€…: Wang M, Song WM, Ming C ç­‰
- å¹´ä»½: 2022
- å¼•ç”¨æ•°: 0
- DOI: [10.1186/s13024-022-00517-z](https://doi.org/10.1186/s13024-022-00517-z)
- PubMed: [PMID:35236372](https://pubmed.ncbi.nlm.nih.gov/35236372/)
- **æåŠå†…å®¹**: "Here we systematically review the state-of-the-art bioinformatics approaches to analyze single-cell sequencing data and their applications to AD in 14 major directions, including 1) quality control and normalization, 2) dimension reduction and feature extraction, 3) cell clustering analysis, 4) cell type inference and annotation, 5) differential expression, 6) trajectory inference, 7) copy number variation analysis, 8) integration of single-cell multi-omics, 9) epigenomic analysis, 10) gene network inference, 11) prioritization of cell subpopulations, 12) integrative analysis of human and mouse sc-RNA-seq data, 13) spatial transcriptomics, and 14) comparison of single cell AD mouse model studies and single cell human AD studies."


## å¸¸ç”¨å·¥å…·/è½¯ä»¶

| å·¥å…· | æåŠè®ºæ–‡æ•° | æ¨èåº¦ |
|------|----------|--------|

## æœ€ä½³å®è·µå»ºè®® (AIç”Ÿæˆ)

# å•ç»†èƒRNAæµ‹åºï¼ˆscRNA-seqï¼‰æ•°æ®åˆ†ææœ€ä½³å®è·µæµç¨‹

åŸºäºé«˜å¼•æ–‡çŒ®çš„ç»¼åˆåˆ†æï¼Œä»¥ä¸‹æ˜¯å½“å‰å•ç»†èƒRNAæµ‹åºæ•°æ®åˆ†æçš„æ ‡å‡†æµç¨‹ã€å…³é”®è¦ç‚¹ã€æ¨èå·¥å…·åŠæœ€æ–°æœ€ä½³å®è·µå»ºè®®ã€‚

---

## 1. æ ‡å‡†scRNA-seqæ•°æ®åˆ†ææµç¨‹ï¼ˆæ­¥éª¤é¡ºåºï¼‰

| æ­¥éª¤ | åç§° |
|------|------|
| 1 | è´¨é‡æ§åˆ¶ï¼ˆQuality Control, QCï¼‰ |
| 2 | æ•°æ®é¢„å¤„ç†ä¸æ ‡å‡†åŒ–ï¼ˆNormalizationï¼‰ |
| 3 | ç‰¹å¾é€‰æ‹©ï¼ˆFeature Selectionï¼‰ |
| 4 | æ•°æ®é™ç»´ï¼ˆDimensionality Reductionï¼‰ |
| 5 | ç»†èƒèšç±»ï¼ˆClusteringï¼‰ |
| 6 | å·®å¼‚è¡¨è¾¾åˆ†æï¼ˆDifferential Expression Analysisï¼‰ |
| 7 | ç»†èƒç±»å‹æ³¨é‡Šï¼ˆCell Type Annotationï¼‰ |
| 8 | è½¨è¿¹æ¨æ–­ä¸å‘è‚²åŠ¨åŠ›å­¦åˆ†æï¼ˆTrajectory Inference / Pseudotime Analysisï¼‰ |
| 9 | å¤šç»„å­¦æ•´åˆä¸è·¨æ¨¡æ€åˆ†æï¼ˆå¯é€‰ï¼ŒMulti-modal Integrationï¼‰ |
| 10 | åŠŸèƒ½å¯Œé›†ä¸ç”Ÿç‰©å­¦è§£é‡Š |

> âœ… **è¯´æ˜**ï¼šè¯¥æµç¨‹ç»¼åˆäº†2019â€“2023å¹´é«˜å¼•æ–‡çŒ®ä¸­çš„å…±è¯†æ€§å»ºè®®ï¼Œå°¤å…¶å‚è€ƒäº† *Luecken et al., 2019* å’Œ *Dominich et al., 2023* çš„æƒå¨ç»¼è¿°ã€‚

---

## 2. æ¯ä¸ªæ­¥éª¤çš„å…³é”®è¦ç‚¹å’Œæ³¨æ„äº‹é¡¹

### **1. è´¨é‡æ§åˆ¶ï¼ˆQuality Controlï¼‰**

- **ç›®çš„**ï¼šå»é™¤ä½è´¨é‡ç»†èƒï¼ˆå¦‚æ­»äº¡ç»†èƒã€ç©ºæ¶²æ»´ã€åŒç»†èƒ/å¤šç»†èƒå¤åˆä½“ï¼‰
- **å…³é”®æŒ‡æ ‡**ï¼š
  - æ¯ä¸ªç»†èƒæ£€æµ‹åˆ°çš„åŸºå› æ•°ï¼ˆnGenes/nFeaturesï¼‰
  - æ€»UMIè®¡æ•°ï¼ˆnCountsï¼‰
  - çº¿ç²’ä½“åŸºå› æ¯”ä¾‹ï¼ˆmitoRatioï¼‰
  - æ ¸ç³–ä½“åŸºå› æ¯”ä¾‹ï¼ˆå¯é€‰ï¼‰
  - å¤–æºæ±¡æŸ“æˆ–çº¢ç»†èƒæ ‡è®°ç‰©è¡¨è¾¾
- **æ³¨æ„äº‹é¡¹**ï¼š
  - é¿å…è¿‡åº¦è¿‡æ»¤å¯¼è‡´ä¸¢å¤±ç¨€æœ‰ç»†èƒç±»å‹
  - ä¸åŒç»„ç»‡/å®éªŒå¹³å°éœ€è°ƒæ•´é˜ˆå€¼
  - ä½¿ç”¨å¯è§†åŒ–æ–¹æ³•ï¼ˆå¦‚æ•£ç‚¹å›¾ã€å¯†åº¦å›¾ï¼‰è¾…åŠ©åˆ¤æ–­å¼‚å¸¸å€¼

---

### **2. æ•°æ®é¢„å¤„ç†ä¸æ ‡å‡†åŒ–ï¼ˆNormalizationï¼‰**

- **ç›®çš„**ï¼šæ¶ˆé™¤æŠ€æœ¯åå·®ï¼ˆå¦‚æµ‹åºæ·±åº¦å·®å¼‚ï¼‰ï¼Œä½¿ä¸åŒç»†èƒé—´å¯æ¯”
- **å¸¸ç”¨æ–¹æ³•**ï¼š
  - LogNormalizeï¼ˆSeuraté»˜è®¤ï¼‰ï¼šå¯¹æ€»UMIè¿›è¡Œå½’ä¸€åŒ–åå–log
  - SCTransformï¼ˆæ¨èï¼‰ï¼šåŸºäºè´ŸäºŒé¡¹åˆ†å¸ƒçš„å›å½’æ¨¡å‹ï¼Œæ›´é€‚ç”¨äºé«˜å˜åŸºå› è¯†åˆ«
- **æ³¨æ„äº‹é¡¹**ï¼š
  - é¿å…ä½¿ç”¨ç®€å•TPM/RPKMç­‰æ‰¹é‡RNA-seqæ–¹æ³•
  - SCTransformèƒ½æ›´å¥½æ ¡æ­£æŠ€æœ¯å™ªå£°å¹¶ä¿ç•™ç”Ÿç‰©å˜å¼‚

---

### **3. ç‰¹å¾é€‰æ‹©ï¼ˆFeature Selectionï¼‰**

- **ç›®çš„**ï¼šç­›é€‰é«˜å˜åŸºå› ï¼ˆHighly Variable Genes, HVGsï¼‰ï¼Œç”¨äºåç»­é™ç»´å’Œèšç±»
- **ç­–ç•¥**ï¼š
  - åŸºäºå‡å€¼-æ–¹å·®å…³ç³»è¯†åˆ«åç¦»éšæœºå™ªå£°çš„åŸºå› 
  - å¯ç»“åˆç”Ÿç‰©å­¦å…ˆéªŒçŸ¥è¯†ï¼ˆå¦‚markeråŸºå› ï¼‰
- **æ³¨æ„äº‹é¡¹**ï¼š
  - è¿‡å°‘HVGså¯èƒ½é—æ¼ä¿¡å·ï¼›è¿‡å¤šåˆ™å¼•å…¥å™ªå£°
  - æ¨èä¿ç•™1,000â€“5,000ä¸ªHVGs

---

### **4. æ•°æ®é™ç»´ï¼ˆDimensionality Reductionï¼‰**

- **ä¸»è¦æ–¹æ³•**ï¼š
  - çº¿æ€§ï¼šä¸»æˆåˆ†åˆ†æï¼ˆPCAï¼‰
  - éçº¿æ€§ï¼št-SNEã€UMAPï¼ˆç”¨äºå¯è§†åŒ–ï¼‰
- **æµç¨‹**ï¼š
  - å…ˆè¿›è¡ŒPCAï¼ˆåœ¨HVGsä¸Šï¼‰
  - é€‰æ‹©å‰Nä¸ªPCsï¼ˆé€šå¸¸10â€“50ï¼‰ç”¨äºä¸‹æ¸¸èšç±»
  - UMAP/t-SNEä»…ç”¨äºå¯è§†åŒ–ï¼Œä¸ç”¨äºèšç±»è¾“å…¥
- **æ³¨æ„äº‹é¡¹**ï¼š
  - UMAPå‚æ•°ï¼ˆå¦‚`n_neighbors`, `min_dist`ï¼‰å½±å“ç»“æœå‘ˆç°ï¼Œéœ€è°¨æ…è°ƒå‚
  - t-SNEæ˜“äº§ç”Ÿâ€œå‡ç°‡â€ï¼Œä¸å®œç”¨äºå®šé‡åˆ†æ

---

### **5. ç»†èƒèšç±»ï¼ˆClusteringï¼‰**

- **ç›®çš„**ï¼šå°†å…·æœ‰ç›¸ä¼¼è¡¨è¾¾è°±çš„ç»†èƒåˆ†ç»„
- **å¸¸ç”¨ç®—æ³•**ï¼š
  - å›¾èšç±»ï¼ˆGraph-basedï¼‰ï¼šLouvainã€Leidenï¼ˆä¸»æµï¼‰
  - K-meansã€Hierarchical clusteringï¼ˆè¾ƒå°‘ç”¨ï¼‰
- **åˆ†è¾¨ç‡è°ƒèŠ‚**ï¼š
  - Leiden/Louvainå…è®¸é€šè¿‡â€œresolutionâ€å‚æ•°æ§åˆ¶ç°‡æ•°é‡
- **æ³¨æ„äº‹é¡¹**ï¼š
  - é«˜åˆ†è¾¨ç‡å¯èƒ½å¯¼è‡´è¿‡åº¦åˆ†å‰²
  - åº”ç»“åˆç”Ÿç‰©å­¦èƒŒæ™¯è¯„ä¼°èšç±»åˆç†æ€§

---

### **6. å·®å¼‚è¡¨è¾¾åˆ†æï¼ˆDifferential Expression, DEï¼‰**

- **ç›®çš„**ï¼šè¯†åˆ«å„ç°‡ç‰¹å¼‚æ€§è¡¨è¾¾çš„åŸºå› ï¼ˆæ½œåœ¨markerï¼‰
- **æ–¹æ³•**ï¼š
  - Wilcoxonç§©å’Œæ£€éªŒï¼ˆSeuraté»˜è®¤ï¼‰
  - MASTã€DESeq2ï¼ˆé€‚ç”¨äºç‰¹å®šè®¾è®¡ï¼‰
  - Tobitæ¨¡å‹ã€Bimodç­‰ä¸“é—¨é’ˆå¯¹dropoutè®¾è®¡çš„æ–¹æ³•
- **è¾“å‡ºå†…å®¹**ï¼š
  - log2 fold changeã€p-valueã€adjusted p-valueï¼ˆFDRï¼‰
  - ä¸Šè°ƒ/ä¸‹è°ƒåŸºå› åˆ—è¡¨
- **æ³¨æ„äº‹é¡¹**ï¼š
  - æ³¨æ„å¤šé‡æ£€éªŒæ ¡æ­£
  - ç»“åˆæ•ˆåº”å¤§å°ï¼ˆfold changeï¼‰è€Œéä»…ä¾èµ–på€¼

---

### **7. ç»†èƒç±»å‹æ³¨é‡Šï¼ˆCell Type Annotationï¼‰**

- **ç­–ç•¥**ï¼š
  - æ‰‹åŠ¨æ³¨é‡Šï¼šåŸºäºå·²çŸ¥markeråŸºå› ï¼ˆå¦‚CD3Eâ†’Tç»†èƒï¼ŒMS4A1â†’Bç»†èƒï¼‰
  - è‡ªåŠ¨æ³¨é‡Šï¼šä½¿ç”¨æ•°æ®åº“é©±åŠ¨å·¥å…·ï¼ˆå¦‚SingleRã€scCATCHã€CellTypistï¼‰
- **æ³¨æ„äº‹é¡¹**ï¼š
  - è‡ªåŠ¨å·¥å…·å¯èƒ½è¯¯åˆ¤ç½•è§æˆ–æ–°å‹ç»†èƒçŠ¶æ€
  - å»ºè®®ç»“åˆå¤šç§æ¥æºéªŒè¯ï¼ˆæ–‡çŒ®ã€æ•°æ®åº“ã€è½¨è¿¹åˆ†æï¼‰
  - æ³¨é‡Šåº”ä½“ç°ç»†èƒçŠ¶æ€ï¼ˆactivation, stressï¼‰è€Œä¸ä»…æ˜¯ç±»å‹

---

### **8. è½¨è¿¹æ¨æ–­ä¸ä¼ªæ—¶é—´åˆ†æï¼ˆTrajectory Inferenceï¼‰**

- **é€‚ç”¨åœºæ™¯**ï¼šè¿ç»­è¿‡ç¨‹ï¼ˆå¦‚åˆ†åŒ–ã€å‘¨æœŸã€æ¿€æ´»ï¼‰
- **å¸¸ç”¨å·¥å…·**ï¼š
  - Monocle3ã€PAGAã€Slingshotã€SCORPIUS
- **æ ¸å¿ƒè¾“å‡º**ï¼š
  - å‘è‚²è½¨è¿¹è·¯å¾„
  - ä¼ªæ—¶é—´ï¼ˆpseudotimeï¼‰æ’åº
  - åˆ†æ”¯ç‚¹è°ƒæ§åŸºå› 
- **æ³¨æ„äº‹é¡¹**ï¼š
  - è½¨è¿¹èµ·ç‚¹è®¾å®šéœ€æœ‰ç”Ÿç‰©å­¦ä¾æ®
  - å¤šæ¡è½¨è¿¹éœ€äº¤å‰éªŒè¯
  - é¿å…å°†æ‰¹æ¬¡æ•ˆåº”è¯¯è®¤ä¸ºè¿ç»­å˜åŒ–

---

### **9. å¤šç»„å­¦æ•´åˆä¸è·¨æ¨¡æ€åˆ†æï¼ˆMulti-modal Integrationï¼‰**

- **èƒŒæ™¯è¶‹åŠ¿**ï¼ˆæ¥è‡ª *Dominich et al., 2023*ï¼‰ï¼š
  - scRNA-seqå¸¸ä¸ATAC-seqã€è›‹ç™½è¡¨è¾¾ï¼ˆCITE-seqï¼‰ã€ç©ºé—´è½¬å½•ç»„è”åˆåˆ†æ
- **æ•´åˆç›®æ ‡**ï¼š
  - åŒ¹é…åŒä¸€ç»†èƒçš„å¤šå±‚ç»„å­¦ä¿¡æ¯
  - æ­ç¤ºè°ƒæ§ç½‘ç»œï¼ˆå¦‚chromatin accessibility â†’ gene expressionï¼‰
- **æ–¹æ³•**ï¼š
  - Seurat v5 WNNï¼ˆweighted nearest neighborï¼‰
  - MOFA+, LIGER, Harmonyï¼ˆç”¨äºæ‰¹æ¬¡/æ¨¡æ€æ ¡æ­£ï¼‰

---

### **10. åŠŸèƒ½å¯Œé›†ä¸ç”Ÿç‰©å­¦è§£é‡Š**

- **å¸¸è§åˆ†æ**ï¼š
  - GOã€KEGGã€Reactomeé€šè·¯å¯Œé›†
  - GSEAï¼ˆåŸºå› é›†å¯Œé›†åˆ†æï¼‰
  - TFæ´»æ€§é¢„æµ‹ï¼ˆå¦‚AUCellã€DoRothEAï¼‰
  - ç»†èƒäº’ä½œåˆ†æï¼ˆå¦‚CellChatã€NicheNetï¼‰
- **æ³¨æ„äº‹é¡¹**ï¼š
  - ä½¿ç”¨é€‚åˆå•ç»†èƒæ•°æ®çš„å¯Œé›†æ–¹æ³•ï¼ˆé¿å…å¿½ç•¥è¡¨è¾¾ç¨€ç–æ€§ï¼‰
  - å¼ºè°ƒæœºåˆ¶å‡è®¾ç”Ÿæˆè€Œéå•ä¸€ç»“è®º

---

## 3. æ¨èå·¥å…·/è½¯ä»¶

| æ­¥éª¤ | æ¨èå·¥å…· | è¯´æ˜ |
|------|----------|------|
| è´¨æ§ & é¢„å¤„ç† | **Seurat** (R), **Scanpy** (Python) | ä¸»æµå…¨æµç¨‹æ¡†æ¶ |
| æ ‡å‡†åŒ– | `SCTransform` (Seurat), `normalize_total + log1p` (Scanpy) | æ¨èSCTransformæå‡ç¨³å®šæ€§ |
| ç‰¹å¾é€‰æ‹© | `FindVariableFeatures` (Seurat), `highly_variable_genes` (Scanpy) | åŸºäºåˆ†æ•£åº¦æˆ–æ®‹å·® |
| é™ç»´ | `RunPCA`, `RunUMAP`, `RunTSNE` | PCAç”¨äºèšç±»ï¼ŒUMAPç”¨äºå¯è§†åŒ– |
| èšç±» | `FindClusters` (Leiden/Louvain), `leidenalg` | æ¨èLeidenç®—æ³• |
| å·®å¼‚è¡¨è¾¾ | `FindAllMarkers`, `FindMarkers` | Wilcoxonä¸ºé»˜è®¤é¦–é€‰ |
| ç»†èƒæ³¨é‡Š | **SingleR**, **CellTypist**, **scCATCH**, **Azimuth** | è‡ªåŠ¨+æ‰‹åŠ¨ç»“åˆ |
| è½¨è¿¹åˆ†æ | **Monocle3**, **PAGA**, **Slingshot** | Monocle3æ”¯æŒå¤§è§„æ¨¡æ•°æ® |
| å¤šç»„å­¦æ•´åˆ | **Seurat WNN**, **Harmony**, **MOFA+** | æ”¯æŒRNA+ADT/ATAK/CNVç­‰ |
| åŠŸèƒ½åˆ†æ | **clusterProfiler**, **AUCell**, **CellChat** | é€šè·¯ã€TFã€äº’ä½œç½‘ç»œ |

---

## 4. å¸¸è§çš„è´¨é‡æ§åˆ¶æ ‡å‡†ï¼ˆQC Metricsï¼‰

| æŒ‡æ ‡ | æ¨èèŒƒå›´ | å¼‚å¸¸æƒ…å†µ |
|------|---------|--------|
| nGenesï¼ˆæ¯ç»†èƒæ£€æµ‹åŸºå› æ•°ï¼‰ | > 500 â€“ 5,000ï¼ˆä¾ç»„ç»‡è€Œå®šï¼‰ | < 200ï¼šç–‘ä¼¼ç©ºæ¶²æ»´ï¼›> 6,000ï¼šå¯èƒ½åŒç»†èƒ |
| nCountsï¼ˆæ€»UMIæ•°ï¼‰ | ä¸­ä½æ•°é™„è¿‘åˆç†åˆ†å¸ƒ | æä½ï¼šæ­»äº¡ç»†èƒï¼›æé«˜ï¼šåŒç»†èƒæˆ–å¤šç»†èƒ |
| çº¿ç²’ä½“åŸºå› æ¯”ä¾‹ | < 10%ï¼ˆè´´å£ç»†èƒï¼‰< 20%ï¼ˆæ‚¬æµ®/åº”æ¿€æ ·æœ¬ï¼‰ | > 20%ï¼šå¼ºçƒˆæç¤ºç»†èƒè£‚è§£æˆ–å‡‹äº¡ |
| æ ¸ç³–ä½“åŸºå› æ¯”ä¾‹ | æ­£å¸¸èŒƒå›´å†…æ³¢åŠ¨ | æ˜¾è‘—å‡é«˜å¯èƒ½æç¤ºåº”æ¿€æˆ–ç¿»è¯‘æ´»è·ƒ |
| doublet score | ä½¿ç”¨DoubletFinderæˆ–Scrubleté¢„æµ‹ | é«˜åˆ†ç»†èƒå»ºè®®å‰”é™¤æˆ–å•ç‹¬åˆ†æ |

> âš ï¸ **æ³¨æ„**ï¼šæ‰€æœ‰é˜ˆå€¼åº”æ ¹æ®å…·ä½“å®éªŒæ¡ä»¶åŠ¨æ€è°ƒæ•´ï¼Œä¸å¯ä¸€åˆ€åˆ‡ã€‚

---

## 5. æœ€æ–°çš„æœ€ä½³å®è·µå»ºè®®ï¼ˆæˆªè‡³2023â€“2024ï¼‰

### âœ… **æ ¸å¿ƒåŸåˆ™**
1. **å¯é‡å¤æ€§ä¼˜å…ˆ**ï¼šè®°å½•å®Œæ•´å‚æ•°ã€ç‰ˆæœ¬ã€éšæœºç§å­
2. **æ¨¡å—åŒ–æµç¨‹**ï¼šä½¿ç”¨Snakemakeã€Nextflowæ„å»ºè‡ªåŠ¨åŒ–pipeline
3. **äº¤äº’å¼æ¢ç´¢**ï¼šç»“åˆR/Shinyæˆ–Python/Jupyterè¿›è¡ŒåŠ¨æ€åˆ†æ
4. **å…ƒæ•°æ®è§„èŒƒ**ï¼šéµå¾ªMIxS-scæ ‡å‡†ï¼Œè¯¦ç»†è®°å½•æ ·æœ¬æ¥æºã€å¤„ç†æ‰¹æ¬¡ã€ä¾›ä½“ä¿¡æ¯

### ğŸ“Œ **æŠ€æœ¯æ›´æ–°è¦ç‚¹**
- **æ¨èä½¿ç”¨SCTransformæ›¿ä»£LogNormalize**  
  ï¼ˆLuecken et al., 2019; Dominich et al., 2023ï¼‰
- **ä¼˜å…ˆé‡‡ç”¨UMAPè€Œét-SNEè¿›è¡Œå¯è§†åŒ–**  
  ï¼ˆæ”¶æ•›æ›´å¿«ï¼Œç»“æ„ä¿æŒæ›´å¥½ï¼‰
- **ä½¿ç”¨Leidenç®—æ³•ä»£æ›¿Louvainèšç±»**  
  ï¼ˆæ›´ç¨³å®šï¼Œåˆ†è¾¨ç‡å¯æ§ï¼‰
- **æ•´åˆè‡ªåŠ¨æ³¨é‡Šä¸äººå·¥éªŒè¯**  
  ï¼ˆé¿å…åå€šï¼Œæå‡å‡†ç¡®æ€§ï¼‰
- **é‡è§†æ‰¹æ¬¡æ•ˆåº”æ ¡æ­£**  
  - å·¥å…·æ¨èï¼š`Harmony`, `BBKNN`, `Scanorama`
  - å®éªŒè®¾è®¡é˜¶æ®µå³è€ƒè™‘æ··æ ·ï¼ˆå¦‚CellPlexï¼‰

### ğŸ”¬ **å‰æ²¿æ–¹å‘**
- **æ·±åº¦å­¦ä¹ åº”ç”¨**ï¼ˆå‚è€ƒ *Zhang et al., 2022*ï¼‰ï¼š
  - è‡ªç¼–ç å™¨ç”¨äºé™ç»´ï¼ˆscVI, scANVIï¼‰
  - å›¾ç¥ç»ç½‘ç»œç”¨äºç»†èƒçŠ¶æ€é¢„æµ‹
- **ç©ºé—´è½¬å½•ç»„è”åˆåˆ†æ**ï¼š
  - ä½¿ç”¨Seuratã€SpaGCNã€Tangramè¿›è¡Œspot-to-cellæ˜ å°„
- **ä¸´åºŠè½¬åŒ–è€ƒé‡**ï¼ˆ*Chen et al., 2022*ï¼‰ï¼š
  - å¼€å‘ç¨³å¥çš„signature panelç”¨äºè¯Šæ–­
  - å…³æ³¨å¯æ“ä½œæ€§ï¼ˆactionable insightsï¼‰è€Œéä»…å‘ç°æ–°ç°‡

---

## å‚è€ƒæ–‡çŒ®

1. Luecken MD, Theis FJ. *Current best practices in single-cell RNA-seq analysis: a tutorial.* Mol Syst Biol. 2019;15(6):e8746. (å¼•ç”¨: 1641)
2. Dominich PA, et al. *Best practices for single-cell analysis across modalities.* Nat Rev Genet. 2023;24(7):427â€“445. (å¼•ç”¨: 603)
3. Tian L, et al. *Tutorial: guidelines for computational analysis of scRNA-seq data.* Nat Protoc. 2021;16(1):67â€“107. (å¼•ç”¨: 236)
4. Kiselev VY, et al. *Tutorial: annotating single-cell transcriptomic maps.* Nat Protoc. 2021;16(1):591â€“609. (å¼•ç”¨: 169)
5. Chen J, et al. *Data analysis guidelines for scRNA-seq in biomedical studies.* Genome Med. 2022;14(1):120. (å¼•ç”¨: 71)
6. Zhang X, et al. *Application of Deep Learning on scRNA-seq Data Analysis: A Review.* Front Genet. 2022;13:808368. (å¼•ç”¨

---

*æŠ¥å‘Šç”Ÿæˆæ—¶é—´: 2025-12-04 20:44:46*
